Literature DB >> 16207466

Innate immune response to adenovirus.

Shoab A Nazir1, Jordan P Metcalf.   

Abstract

Adenovirus is a common infectious pathogen in both children and adults. It is a significant cause of morbidity in immunocompetent people living in crowded living conditions and of mortality in immunocompromised hosts. It has more recently become a popular vehicle for gene therapy applications. The host response to wild-type infection and gene therapy vector exposure involves both the innate and adaptive immune systems. The initial innate immune response is associated with the severe acute manifestations of adenovirus infection and also plays a significant role in acute toxicity owing to adenovirus vector exposure. This review discusses the innate immune response primarily during wild-type adenovirus infection because this serves as the basis for understanding the response during both natural infection and exposure to adenovirus vectors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16207466     DOI: 10.2310/6650.2005.53605

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


  13 in total

1.  Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus Vaccine.

Authors:  J Brian Kimble; Delphine C Malherbe; Michelle Meyer; Bronwyn M Gunn; Marcus M Karim; Philipp A Ilinykh; Mathieu Iampietro; Khaled S Mohamed; Surendra Negi; Pavlo Gilchuk; Kai Huang; Yuri I Wolf; Werner Braun; James E Crowe; Galit Alter; Alexander Bukreyev
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

Review 2.  Matrices and scaffolds for DNA delivery in tissue engineering.

Authors:  Laura De Laporte; Lonnie D Shea
Journal:  Adv Drug Deliv Rev       Date:  2007-04-14       Impact factor: 15.470

3.  Airway delivery of an adenovirus-based Ebola virus vaccine bypasses existing immunity to homologous adenovirus in nonhuman primates.

Authors:  Jason S Richardson; Stéphane Pillet; Alexander J Bello; Gary P Kobinger
Journal:  J Virol       Date:  2013-01-09       Impact factor: 5.103

4.  Evaluation of protective immune response in mice by vaccination the recombinant adenovirus for expressing Schistosoma japonicum inhibitor apoptosis protein.

Authors:  Chao Hu; Lihui Zhu; Rong Luo; Jinwei Dao; Jiangping Zhao; Yaojun Shi; Hao Li; Ke Lu; Xingang Feng; Jiaojiao Lin; Jinming Liu; Guofeng Cheng
Journal:  Parasitol Res       Date:  2014-09-04       Impact factor: 2.289

5.  Human adenovirus type 37 and the BALB/c mouse: progress toward a restricted adenovirus keratitis model (an American Ophthalmological Society thesis).

Authors:  James Chodosh
Journal:  Trans Am Ophthalmol Soc       Date:  2006

Review 6.  New insights on adenovirus as vaccine vectors.

Authors:  Marcio O Lasaro; Hildegund C J Ertl
Journal:  Mol Ther       Date:  2009-06-09       Impact factor: 11.454

7.  Inhibition of Jak1-dependent signal transduction in airway epithelial cells infected with adenovirus.

Authors:  Lei Shi; Murali Ramaswamy; Lori J Manzel; Dwight C Look
Journal:  Am J Respir Cell Mol Biol       Date:  2007-07-19       Impact factor: 6.914

8.  Rapamycin enhances adenovirus-mediated cancer imaging and therapy in pre-immunized murine hosts.

Authors:  Ziyue Karen Jiang; Mai Johnson; Diana L Moughon; Jennifer Kuo; Makoto Sato; Lily Wu
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

9.  Enhanced protection against Ebola virus mediated by an improved adenovirus-based vaccine.

Authors:  Jason S Richardson; Michel K Yao; Kaylie N Tran; Maria A Croyle; James E Strong; Heinz Feldmann; Gary P Kobinger
Journal:  PLoS One       Date:  2009-04-23       Impact factor: 3.240

Review 10.  The evolution of adenoviral vectors through genetic and chemical surface modifications.

Authors:  Cristian Capasso; Mariangela Garofalo; Mari Hirvinen; Vincenzo Cerullo
Journal:  Viruses       Date:  2014-02-17       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.